Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a ...

Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...

The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...

Rajesh Menon said, “We are pleased to appoint Zeal Global Corp as our new General Sales Agent for our cargo operations in ...

More than 40% of patients with longstanding prurigo nodularis (PN) had significant improvement within 3 months of starting ...

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup ...

2 NOT FOR UK USE NOT INTENDED FOR UK MEDIA LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 ...

The Johns Hopkins surgeon highlighted rapid growth at the agency, but pledged key staff will have “all the resources they ...

The U.S. pharma major has now titled the webpage “Merit-Based Diversity, Equity, and Inclusion,” revising the former title “Diversity, Equity, and Inclusion.” According to Stat News ...

JMP Securities analyst Jason Butler reiterated a Hold rating on Athira Pharma (ATHA – Research Report) today. The company’s shares closed yesterday at $0.42. See what stocks are receiving ...

Entering the post-approval phase marks a critical pivot for pharmaceutical companies, shifting their focus from the scientific aspects of drug development to the multifaceted challenges of ...